IP Library Granted Patent US 8,329,876
Granted Patent B2
US 8,329,876 · App. 13/282,129 · Granted Dec 11, 2012

Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,329,876
App. No.
13/282,129
Granted
Dec 11, 2012
Kind
B2
Abstract

The invention provides reagents and methods for conjugating a polymer specifically to the α-amine of a polypeptide. The invention provides monofunctional, bifunctional, and multifunctional PEGs and related polymers having a terminal thioester moiety capable of specifically conjugating to the α-amine of a polypeptide having a cysteine or histidine residue at the N-terminus. The invention provides reactive thioester-terminated PEG polymers that have suitable reactivity with an N-terminal cysteine or histidine residue of a polypeptide to produce an amide bond between the PEG molecule and the polypeptide.

Claims (28)

1. A composition comprising a conjugate having the structure:

wherein:

R′ is a central core molecule;

POLY is a water-soluble and non-peptidic polymer backbone;

Z is a linker;

a is 0 or 1;

m is from 0 to about 12;

each X is independently selected from H and alkyl;

Y is a heteroatom;

W is CH 2 SH or

POLYPEPTIDE is a residue of a polypeptide molecule; and

y is from 3 to about 100.

2. The composition of claim 1 , wherein the central core molecule, R′, is a residue of a polyol having at least three hydroxyl groups.

3. The composition of claim 2 , wherein the polyol is selected from the group consisting of glycerol, hexaglycerol, sorbitol and pentaerythritol.

4. The composition of claim 3 , wherein the polyol is pentaerythritol.

5. The composition of claim 1 , wherein the water-soluble and non-peptidic polymer backbone, POLY, is a poly(ethylene glycol).

6. The composition of claim 1 , wherein the poly(ethylene glycol) has a molecular weight of about 100 Da to about 100,000 Da.

7. The composition of claim 1 , wherein the linker, Z, is selected from the group consisting of —O—, —S—, —NHCO—, —CONH—, —O 2 C—, —NH—CO 2 — and —O 2 CNH—.

8. The composition of claim 1 , wherein the linker, Z, is —NHCO—.

9. The composition of claim 1 , wherein m is 1 to about 4.

10. The composition of claim 8 , wherein m is 2.

11. The composition of claim 1 , wherein the hetereoatom, Y, is O or S.

12. The composition of claim 11 , wherein the heteroatom, Y, is O.

13. The composition of claim 1 , wherein W is CH 2 SH.

14. The composition of claim 1 , wherein W is

15. The composition of claim 1 , wherein y is 3 to about 25.

16. The composition of claim 15 , wherein y is 3-10.

17. The composition of claim 16 , wherein y is 4.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →